New insider activity at Cryo-Cell International ( (CCEL) ) has taken place on September 10, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chairman and Co-CEO David Portnoy has made a significant investment in Cryo-Cell International by purchasing 42,900 shares of the company’s stock. This acquisition is valued at $189,985, highlighting Portnoy’s confidence in the company’s potential.
Recent Updates on CCEL stock
Cryo-Cell International (CCEL) has announced that it will not declare a quarterly cash dividend for the third quarter of fiscal 2025 due to lower-than-expected profitability. This decision reflects the company’s financial performance challenges, including stable revenue but significant issues with profitability and the balance sheet. Analysts have rated the stock as a Hold with a price target of $4.50, citing a neutral technical analysis trend and valuation concerns, which are somewhat offset by a high dividend yield. The absence of earnings call and corporate events data further limits insights into the company’s future performance.
Spark’s Take on CCEL Stock
According to Spark, TipRanks’ AI Analyst, CCEL is a Neutral.
Cryo-Cell International’s overall stock score reflects a balance of financial challenges and technical neutrality. The most significant factor is the financial performance, which shows stable revenue but significant profitability and balance sheet issues. Technical analysis indicates a neutral trend, while valuation concerns are offset by a high dividend yield. The absence of earnings call and corporate events data limits further insights.
To see Spark’s full report on CCEL stock, click here.
More about Cryo-Cell International
YTD Price Performance: -35.60%
Average Trading Volume: 13,921
Technical Sentiment Signal: Sell
Current Market Cap: $34.81M